The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ondansetron     Quarter: 2016Q3

Total Records: 1,451     Number of Pages: 73

DRUGNAME PT EventCount
ONDANSETRON HYDROCHLORIDE. Peripheral swelling 3
ONDANSETRON HYDROCHLORIDE. Pruritus 3
ONDANSETRON HYDROCHLORIDE. Pulmonary artery stenosis congenital 3
ONDANSETRON HYDROCHLORIDE. Pulmonary valve stenosis congenital 3
ONDANSETRON HYDROCHLORIDE. Rhinorrhoea 3
ONDANSETRON HYDROCHLORIDE. Selective eating disorder 3
ONDANSETRON HYDROCHLORIDE. Spine malformation 3
ONDANSETRON HYDROCHLORIDE. Stress 3
ONDANSETRON HYDROCHLORIDE. Talipes 3
ONDANSETRON HYDROCHLORIDE. Transient tachypnoea of the newborn 3
ONDANSETRON HYDROCHLORIDE. Upper respiratory tract infection 3
Ondansetron Injection (4420-01) Cardiac arrest 3
ONDANSETRON ORALLY DISINTEGRATING TABLETS Drug ineffective for unapproved indication 3
ONDANSETRON ORALLY DISINTEGRATING TABLETS Headache 3
ONDANSETRON ORALLY DISINTEGRATING TABLETS Off label use 3
ONDANSETRON ORALLY DISINTEGRATING TABLETS Product solubility abnormal 3
ONDANSETRON TEVA//ONDANSETRON Congenital anomaly 3
ONDANSETRON TEVA//ONDANSETRON Multiple congenital abnormalities 3
ONDANSETRON TEVA//ONDANSETRON Ventricular septal defect 3
ONDANSETRON. Cardiac murmur 3

Total Records: 1,451     Number of Pages: 73